Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Vuga, Louis J ^a   Milosevic, Jadranka ^a   Pandit, Kusum ^a   Ben Yehudah, Ahmi ^b   Chu, Yanxia ^a   Richards, Thomas ^a   Sciurba, Joshua ^a   Myerburg, Michael ^a   Zhang, Yingze ^a   Parwani, Anil V ^a   Gibson, Kevin F ^a   Kaminski, Naftali ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; MESSENGER RNA; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COMP GENE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG FIBROBLAST; LUNG PARENCHYMA; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; WESTERN BLOTTING;

AGED; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CELLS, CULTURED; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

EID: 84893440499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083120     Document Type: Article

References (58)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, et al. (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824.
2. Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, et al. (2001) Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164: 1722-1727. (Pubitemid 33124165)
3. Lynch JP 3rd, Saggar R, Weigt SS, Zisman DA, White ES (2006) Usual interstitial pneumonia. Semin Respir Crit Care Med 27: 634-651. (Pubitemid 46048043)
4. Selman M, King TE, Pardo A (2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151. (Pubitemid 32096342)
5. Pottier N, Maurin T, Chevalier B, Puissegur MP, Lebrigand K, et al. (2009) Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 4: e6718.
6. Willis BC, Borok Z (2007) TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293: L525-534. (Pubitemid 47358808)
7. Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, et al. (2010) Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182: 220-229.
8. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, et al. (2002) Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A 99: 6292-6297. (Pubitemid 34493305)
9. Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, et al. (2004) Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med 170: 242-251. (Pubitemid 38971408)
10. Pardo A, Gibson K, Cisneros J, Richards TJ, Yang Y, et al. (2005) Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2: e251.
11. Selman M, Pardo A, Barrera L, Estrada A, Watson SR, et al. (2006) Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 173: 188-198. (Pubitemid 43187891)
12. Bridges RS, Kass D, Loh K, Glackin C, Borczuk AC, et al. (2009) Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular "rectifier" of growth factor signaling. Am J Pathol 175: 2351-2361.
13. Hsu E, Shi H, Jordan RM, Lyons-Weiler J, Pilewski JM, et al. (2011) Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum 63: 783-794.
14. Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, et al. (2006) Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203: 2895-2906. (Pubitemid 46026167)
15. Englert JM, Hanford LE, Kaminski N, Tobolewski JM, Tan RJ, et al. (2008) A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 172: 583-591. (Pubitemid 351354532)
16. Vuga LJ, Ben-Yehudah A, Kovkarova-Naumovski E, Oriss T, Gibson KF, et al. (2009) WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol 41: 583-589.
17. Konishi K, Gibson KF, Lindell KO, Richards TJ, Zhang Y, et al. (2009) Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 180: 167-175.
18. DiCesare PE, Morgelin M, Carlson CS, Pasumarti S, Paulsson M (1995) Cartilage oligomeric matrix protein: isolation and characterization from human articular cartilage. J Orthop Res 13: 422-428.
19. Haudenschild DR, Hong E, Yik JH, Chromy B, Morgelin M, et al. (2011) Enhanced activity of transforming growth factor beta1 (TGF-beta1) bound to cartilage oligomeric matrix protein. J Biol Chem 286: 43250-43258.
20. Newton G, Weremowicz S, Morton CC, Copeland NG, Gilbert DJ, et al. (1994) Characterization of human and mouse cartilage oligomeric matrix protein. Genomics 24: 435-439.
21. Thur J, Rosenberg K, Nitsche DP, Pihlajamaa T, Ala-Kokko L, et al. (2001) Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J Biol Chem 276: 6083-6092.
22. Mann HH, Ozbek S, Engel J, Paulsson M, Wagener R (2004) Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem 279: 25294-25298. (Pubitemid 38756782)
23. Holden P, Meadows RS, Chapman KL, Grant ME, Kadler KE, et al. (2001) Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem 276: 6046-6055.
24. Halasz K, Kassner A, Morgelin M, Heinegard D (2007) COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 282: 31166-31173. (Pubitemid 350044871)
25. Chaganti RK, Kelman A, Lui L, Yao W, Javaid MK, et al. (2008) Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis. Osteoarthritis Cartilage 16: 566-571.
26. Smith RK, Zunino L, Webbon PM, Heinegard D (1997) The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 16: 255-271. (Pubitemid 27503812)
27. Hesselstrand R, Kassner A, Heinegard D, Saxne T (2008) COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker. Ann Rheum Dis 67: 1242-1248.
28. Neidhart M, Zaucke F, von Knoch R, Jungel A, Michel BA, et al. (2005) Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein. Ann Rheum Dis 64: 419-424. (Pubitemid 40283053)
29. Chen FH, Thomas AO, Hecht JT, Goldring MB, Lawler J (2005) Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J Biol Chem 280: 32655-32661. (Pubitemid 41368309)
30. Inui S, Shono F, Nakajima T, Hosokawa K, Itami S (2011) Identification and characterization of cartilage oligomeric matrix protein as a novel pathogenic factor in keloids. Am J Pathol 179: 1951-1960.
31. Yamamoto M, Takahashi H, Suzuki C, Naishiro Y, Yamamoto H, et al. (2007) Cartilage oligomeric matrix protein in systemic sclerosis. Rheumatology (Oxford) 46: 1858-1859. (Pubitemid 350168305)
32. Farina G, Lemaire R, Korn JH, Widom RL (2006) Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts. Matrix Biol 25: 213-222. (Pubitemid 43729069)
33. Farina G, Lemaire R, Pancari P, Bayle J, Widom RL, et al. (2009) Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta. Ann Rheum Dis 68: 435-441.
34. Canfield AE, Farrington C, Dziobon MD, Boot-Handford RP, Heagerty AM, et al. (2002) The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. J Pathol 196: 228-234. (Pubitemid 34110905)
35. Wislowska M, Jablonska B (2005) Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication. Rheumatol Int 25: 373-378. (Pubitemid 40922255)
36. Kim W, Moon SO, Lee SY, Jang KY, Cho CH, et al. (2006) COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol 17: 2474-2483. (Pubitemid 44300963)
37. Liao Q, Kleeff J, Xiao Y, Di Cesare PE, Korc M, et al. (2003) COMP is selectively up-regulated in degenerating acinar cells in chronic pancreatitis and in chronic-pancreatitis-like lesions in pancreatic cancer. Scand J Gastroenterol 38: 207-215. (Pubitemid 36349934)
38. Xiao Y, Kleeff J, Guo J, Gazdhar A, Liao Q, et al. (2004) Cartilage oligomeric matrix protein expression in hepatocellular carcinoma and the cirrhotic liver. J Gastroenterol Hepatol 19: 296-302. (Pubitemid 38338739)
39. Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, et al. (2012) Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol 47: 879-887.
40. Gilani SR, Vuga LJ, Lindell KO, Gibson KF, Xue J, et al. (2010) CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 5: e8959.
41. Demedts M, Costabel U (2002) ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J 19: 794-796. (Pubitemid 34567889)
42. King TE, Jr., Tooze JA, Schwarz MI, Brown KR, Cherniack RM (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164: 1171-1181. (Pubitemid 33052246)
43. Yan J, Fine J (2004) Estimating equations for association structures. Stat Med 23: 859-874; discussion 875-857,879-880.
44. Khalil N, Xu YD, O'Connor R, Duronio V (2005) Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. J Biol Chem 280: 43000-43009. (Pubitemid 43049264)
45. Ikegawa S, Ohashi H, Nishimura G, Kim KC, Sannohe A, et al. (1998) Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia. Hum Genet 103: 633-638. (Pubitemid 29020756)
46. Deere M, Sanford T, Ferguson HL, Daniels K, Hecht JT (1998) Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia. Am J Med Genet 80: 510-513. (Pubitemid 29002020)
47. Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H, et al. (1995) Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 10: 330-336.
48. Chen HC, Shah SH, Li YJ, Stabler TV, Jordan JM, et al. (2008) Inverse association of general joint hypermobility with hand and knee osteoarthritis and serum cartilage oligomeric matrix protein levels. Arthritis Rheum 58: 3854-3864.
49. Tufan AC, Satiroglu-Tufan NL, Jackson GC, Semerci CN, Solak S, et al. (2007) Serum or plasma cartilage oligomeric matrix protein concentration as a diagnostic marker in pseudoachondroplasia: differential diagnosis of a family. Eur J Hum Genet 15: 1023-1028. (Pubitemid 47491456)
50. Stanescu R, Stanescu V, Muriel MP, Maroteaux P (1993) Multiple epiphyseal dysplasia, Fairbank type: morphologic and biochemical study of cartilage. Am J Med Genet 45: 501-507. (Pubitemid 23029647)
51. Hansen U, Platz N, Becker A, Bruckner P, Paulsson M, et al. (2011) A secreted variant of cartilage oligomeric matrix protein carrying a chondrodysplasia-causing mutation (p.H587R) disrupts collagen fibrillogenesis. Arthritis Rheum 63: 159-167.
52. Hesselstrand R, Andreasson K, Wuttge DM, Bozovic G, Scheja A, et al. (2012) Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease. Rheumatology (Oxford) 51: 915-920.
53. Pardo A, Selman M, Kaminski N (2008) Approaching the degradome in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 40: 1141-1155.
54. Agarwal P, Schulz JN, Blumbach K, Andreasson K, Heinegard D, et al. (2013) Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies. Matrix Biol 32: 325-331.
55. Zhou Y, Huang X, Hecker L, Kurundkar D, Kurundkar A, et al. (2013) Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Invest 123: 1096-1108.
56. Kadota J, Mizunoe S, Mito K, Mukae H, Yoshioka S, et al. (2005) High plasma concentrations of osteopontin in patients with interstitial pneumonia. Respir Med 99: 111-117. (Pubitemid 40017394)
57. Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Kawayama T, et al. (2011) Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 37: 1119-1127.
58. Korthagen NM, van Moorsel CH, Barlo NP, Ruven HJ, Kruit A, et al. (2011) Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis. Respir Med 105: 106-113.